TNDM Tandem Diabetes Care Inc

Price (delayed)

$61.52

Market cap

$3.93B

P/E Ratio

683.56

Dividend/share

N/A

EPS

$0.09

Enterprise value

$4.26B

Tandem Diabetes Care is a public US medical device manufacturer based in San Diego, CA. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy. ...

Highlights
The company's equity rose by 40% YoY
Tandem Diabetes Care's gross profit has increased by 39% YoY and by 4.7% from the previous quarter
The net income has soared by 124% YoY but it has plunged by 62% from the previous quarter
Tandem Diabetes Care's EPS has soared by 123% YoY but it has plunged by 64% from the previous quarter
The debt has increased by 33% from the previous quarter and by 32% YoY
Tandem Diabetes Care's quick ratio has decreased by 2.6% YoY

Key stats

What are the main financial stats of TNDM
Market
Shares outstanding
63.96M
Market cap
$3.93B
Enterprise value
$4.26B
Valuations
Price to earnings (P/E)
683.56
Price to book (P/B)
8.98
Price to sales (P/S)
5.33
EV/EBIT
399.18
EV/EBITDA
172.76
EV/Sales
5.78
Earnings
Revenue
$737.67M
EBIT
$10.67M
EBITDA
$24.66M
Free cash flow
$83.18M
Per share
EPS
$0.09
Free cash flow per share
$1.3
Book value per share
$6.85
Revenue per share
$11.55
TBVPS
$15.89
Balance sheet
Total assets
$1.02B
Total liabilities
$577.9M
Debt
$419.18M
Equity
$437.38M
Working capital
$686.65M
Liquidity
Debt to equity
0.96
Current ratio
6.21
Quick ratio
5.53
Net debt/EBITDA
13.2
Margins
EBITDA margin
3.3%
Gross margin
53.4%
Net margin
0.8%
Operating margin
1.4%
Efficiency
Return on assets
0.7%
Return on equity
1.5%
Return on invested capital
1.1%
Return on capital employed
1.2%
Return on sales
1.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TNDM stock price

How has the Tandem Diabetes Care stock price performed over time
Intraday
4.75%
1 week
9.06%
1 month
-5.77%
1 year
-36.06%
YTD
-59.13%
QTD
-47.1%

Financial performance

How have Tandem Diabetes Care's revenue and profit performed over time
Revenue
$737.67M
Gross profit
$394.02M
Operating income
$10.55M
Net income
$5.9M
Gross margin
53.4%
Net margin
0.8%
The net income has soared by 124% YoY but it has plunged by 62% from the previous quarter
The net margin has soared by 118% YoY but it has plunged by 64% from the previous quarter
The operating margin has plunged by 56% from the previous quarter
The operating income has shrunk by 53% QoQ

Growth

What is Tandem Diabetes Care's growth rate over time

Valuation

What is Tandem Diabetes Care stock price valuation
P/E
683.56
P/B
8.98
P/S
5.33
EV/EBIT
399.18
EV/EBITDA
172.76
EV/Sales
5.78
Tandem Diabetes Care's EPS has soared by 123% YoY but it has plunged by 64% from the previous quarter
TNDM's price to earnings (P/E) is 14% less than its last 4 quarters average of 759.4
TNDM's price to book (P/B) is 60% less than its 5-year quarterly average of 21.4 and 55% less than its last 4 quarters average of 19.0
The company's equity rose by 40% YoY
The P/S is 55% lower than the last 4 quarters average of 11.3 and 48% lower than the 5-year quarterly average of 9.7
TNDM's revenue is up by 36% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Tandem Diabetes Care business performance
Tandem Diabetes Care's ROS has soared by 161% YoY but it has plunged by 55% from the previous quarter
The return on invested capital has surged by 161% year-on-year but it has dropped by 54% since the previous quarter
The return on assets has surged by 119% year-on-year but it has dropped by 63% since the previous quarter
TNDM's ROE has soared by 119% YoY but it has plunged by 64% from the previous quarter

Dividends

What is TNDM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNDM.

Financial health

How did Tandem Diabetes Care financials performed over time
The total assets is 76% greater than the total liabilities
The total assets has increased by 35% year-on-year and by 12% since the previous quarter
The total liabilities has grown by 31% YoY and by 22% from the previous quarter
The debt is 4.2% less than the equity
The company's equity rose by 40% YoY
The debt has increased by 33% from the previous quarter and by 32% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.